Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Other Accumulated Expenses (2022 - 2023)

Historic Other Accumulated Expenses for Dianthus Therapeutics (DNTH) over the last 2 years, with Q2 2023 value amounting to $279000.0.

  • Dianthus Therapeutics' Other Accumulated Expenses changed N/A to $279000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $279000.0, marking a year-over-year change of. This contributed to the annual value of $364000.0 for FY2022, which is N/A changed from last year.
  • As of Q2 2023, Dianthus Therapeutics' Other Accumulated Expenses stood at $279000.0.
  • Over the past 5 years, Dianthus Therapeutics' Other Accumulated Expenses peaked at $364000.0 during Q4 2022, and registered a low of $224000.0 during Q1 2023.